232 related articles for article (PubMed ID: 28982851)
21. Targeting PDK1 in cancer.
Raimondi C; Falasca M
Curr Med Chem; 2011; 18(18):2763-9. PubMed ID: 21568903
[TBL] [Abstract][Full Text] [Related]
22. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
[TBL] [Abstract][Full Text] [Related]
23. Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinoma.
Tokunaga E; Oki E; Kimura Y; Yamanaka T; Egashira A; Nishida K; Koga T; Morita M; Kakeji Y; Maehara Y
Breast Cancer Res Treat; 2007 Mar; 101(3):249-57. PubMed ID: 17006756
[TBL] [Abstract][Full Text] [Related]
24. Small-molecule inhibitors of PDK1.
Peifer C; Alessi DR
ChemMedChem; 2008 Dec; 3(12):1810-38. PubMed ID: 18972468
[TBL] [Abstract][Full Text] [Related]
25. Effects of Tyroserleutide on phosphatidylinositol 3'-kinase/AKT pathway in human hepatocellular carcinoma cell.
Fu Z; Ren L; Wei H; Lv J; Che X; Zhu Z; Jia J; Wang L; Lin G; Lu R; Yao Z
J Drug Target; 2014 Feb; 22(2):146-55. PubMed ID: 24147456
[TBL] [Abstract][Full Text] [Related]
26. Dickkopf-1 (DKK1) phosphatase and tensin homolog on chromosome 10 (PTEN) crosstalk via microRNA interference in the diabetic heart.
Ling S; Birnbaum Y; Nanhwan MK; Thomas B; Bajaj M; Li Y; Li Y; Ye Y
Basic Res Cardiol; 2013 May; 108(3):352. PubMed ID: 23636253
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth.
Edwards LA; Thiessen B; Dragowska WH; Daynard T; Bally MB; Dedhar S
Oncogene; 2005 May; 24(22):3596-605. PubMed ID: 15782140
[TBL] [Abstract][Full Text] [Related]
28. Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation.
Miralem T; Lerner-Marmarosh N; Gibbs PE; Jenkins JL; Heimiller C; Maines MD
FASEB J; 2016 Aug; 30(8):2926-44. PubMed ID: 27166089
[TBL] [Abstract][Full Text] [Related]
29. PARK2 Depletion Connects Energy and Oxidative Stress to PI3K/Akt Activation via PTEN S-Nitrosylation.
Gupta A; Anjomani-Virmouni S; Koundouros N; Dimitriadi M; Choo-Wing R; Valle A; Zheng Y; Chiu YH; Agnihotri S; Zadeh G; Asara JM; Anastasiou D; Arends MJ; Cantley LC; Poulogiannis G
Mol Cell; 2017 Mar; 65(6):999-1013.e7. PubMed ID: 28306514
[TBL] [Abstract][Full Text] [Related]
30. Serine 396 of PDK1 is required for maximal PKB activation.
Moon Z; Wang Y; Aryan N; Mousseau DD; Scheid MP
Cell Signal; 2008 Nov; 20(11):2038-49. PubMed ID: 18718528
[TBL] [Abstract][Full Text] [Related]
31. Effects of wortmannin on phosphorylation of PDK1, GSK3-beta, PTEN and expression of Skp2 mRNA after ischemia/reperfusion injury in the mouse kidney.
Zheng X; Xie L; Qin J; Shen H; Chen Z; Jin Y
Int Urol Nephrol; 2008; 40(1):185-92. PubMed ID: 17975737
[TBL] [Abstract][Full Text] [Related]
32. Growth hormone modulation of EGF-induced PI3K-Akt pathway in mice liver.
Díaz ME; González L; Miquet JG; Martínez CS; Sotelo AI; Bartke A; Turyn D
Cell Signal; 2012 Feb; 24(2):514-523. PubMed ID: 22019461
[TBL] [Abstract][Full Text] [Related]
33. RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1.
Kim DW; Hwang JH; Suh JM; Kim H; Song JH; Hwang ES; Hwang IY; Park KC; Chung HK; Kim JM; Park J; Hemmings BA; Shong M
Mol Endocrinol; 2003 Jul; 17(7):1382-94. PubMed ID: 12738763
[TBL] [Abstract][Full Text] [Related]
34. Selective inhibition of PTEN preserves ischaemic post-conditioning cardioprotection in STZ-induced Type 1 diabetic rats: role of the PI3K/Akt and JAK2/STAT3 pathways.
Xue R; Lei S; Xia ZY; Wu Y; Meng Q; Zhan L; Su W; Liu H; Xu J; Liu Z; Zhou B; Xia Z
Clin Sci (Lond); 2016 Mar; 130(5):377-92. PubMed ID: 26666444
[TBL] [Abstract][Full Text] [Related]
35. Reciprocal regulation of Notch and PI3K/Akt signalling in T-ALL cells in vitro.
Calzavara E; Chiaramonte R; Cesana D; Basile A; Sherbet GV; Comi P
J Cell Biochem; 2008 Apr; 103(5):1405-12. PubMed ID: 17849443
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-21 promotes phosphatase gene and protein kinase B/phosphatidylinositol 3-kinase expression in colorectal cancer.
Sheng WZ; Chen YS; Tu CT; He J; Zhang B; Gao WD
World J Gastroenterol; 2016 Jun; 22(24):5532-9. PubMed ID: 27350731
[TBL] [Abstract][Full Text] [Related]
37. Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines.
Festuccia C; Muzi P; Millimaggi D; Biordi L; Gravina GL; Speca S; Angelucci A; Dolo V; Vicentini C; Bologna M
Endocr Relat Cancer; 2005 Dec; 12(4):983-98. PubMed ID: 16322337
[TBL] [Abstract][Full Text] [Related]
38. Phosphoinositide-dependent protein kinase 1 (PDK1) mediates potent inhibitory effects on eosinophils.
Sturm EM; Parzmair GP; Radnai B; Frei RB; Sturm GJ; Hammer A; Schuligoi R; Lippe IT; Heinemann A
Eur J Immunol; 2015 May; 45(5):1548-59. PubMed ID: 25645675
[TBL] [Abstract][Full Text] [Related]
39. Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers.
Nakahata S; Ichikawa T; Maneesaay P; Saito Y; Nagai K; Tamura T; Manachai N; Yamakawa N; Hamasaki M; Kitabayashi I; Arai Y; Kanai Y; Taki T; Abe T; Kiyonari H; Shimoda K; Ohshima K; Horii A; Shima H; Taniwaki M; Yamaguchi R; Morishita K
Nat Commun; 2014 Feb; 5():3393. PubMed ID: 24569712
[TBL] [Abstract][Full Text] [Related]
40. Ursolic acid-induced apoptosis in K562 cells involving upregulation of PTEN gene expression and inactivation of the PI3K/Akt pathway.
Wu B; Wang X; Chi ZF; Hu R; Zhang R; Yang W; Liu ZG
Arch Pharm Res; 2012 Mar; 35(3):543-8. PubMed ID: 22477202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
